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Somatic Inactivation of Pkd2 Results
in Polycystic Kidney Disease
1995; International Polycystic Kidney Disease Consor-
tium, 1995). Polycystin-1 has 11 membrane spans with
a z2500±amino acid extracellular domain, which in-
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Winfried Edelmann,3,4 and Stefan Somlo1,3,6 egg jelly receptor (Hughes et al., 1995; Moy et al., 1996).
1Department of Medicine The short cytoplasmic COOH terminusof PKD1 contains
2Department of Microbiology and Immunology a coiled-coil domain (Qian et al., 1997).
3Department of Molecular Genetics PKD2, the second gene for ADPKD, is located in
4Department of Cell Biology 4q21±23 and encodes a 968±amino acid integral mem-
Albert Einstein College of Medicine brane protein, polycystin-2, with 6 membrane-spanning
Bronx, New York 10461 domains and intracellularNH2 and COOH termini (Mochi-
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College of Physicians and Surgeons contains an EF-hand domain. There is 25%±30% identity
Columbia University and 45%±50% similarity between polycystin-2 and both
New York, New York 10032 an z450±amino acid portion of polycystin-1 or z270-
residue region of the family of voltage-activated calcium
channel a1 subunits. A third ADPKD gene has been impli-
Summary cated as a rare cause of the disease but has not been
mapped (Daoust et al., 1995).
Germline mutations in PKD2 cause autosomal domi- PKD1 and PKD2 are widely expressed in fetal and
nant polycystic kidney disease. We have introduced a adult tissues (Mochizuki et al., 1996; Ward et al., 1996).
mutant exon 1 in tandem with the wild-type exon 1 at The immunohistochemical staining profile of PKD2 has
the mouse Pkd2 locus. This is an unstable allele that not been reported. PKD1 is expressed in tubular epithe-
undergoes somatic inactivation by intragenic homolo- lial cells (Griffin et al., 1996; Palsson et al., 1996; Peters
gous recombination to produce a true null allele. Mice et al., 1996; Ward et al., 1996; Ibraghimov-Beskrovnaya
heterozygous and homozygous for this mutation, as et al., 1997), and its expression is developmentally regu-
well as Pkd1/2 mice, develop polycystic kidney and lated (Geng et al., 1996; van Adelsberg et al., 1997).
liver lesions that are indistinguishable from the human Recently, a mouse model deleting exon 34 of Pkd1 has
phenotype. In all cases, renal cysts arise from renal confirmed a role for Pkd1 during development (Lu et al.,
tubular cells that lose the capacity to produce Pkd2
1997). In ADPKD, all nephron segments can give rise to
protein. Somatic loss of Pkd2 expression is both
cysts; however, the process is focal, with only a smallnecessary and sufficient for renal cyst formation in
fraction of nephrons involved in cyst formation (GabowADPKD, suggesting that PKD2 occurs by a cellular
and Grantham, 1997). Cyst-lining cells have been char-recessive mechanism.
acterized as being in a less-well-differentiated state than
the tubular epithelial cells from which they are derived
(Calvet, 1993).Introduction
It has been hypothesized that polycystin-1 acts as a
receptor for either cell±matrix or cell±cell interactionsAutosomal dominant polycystic kidney disease (ADPKD)
(American PKD1 Consortium, 1995; Hughes et al., 1995;consists of at least three genetically distinct disorders
International Polycystic Kidney Disease Consortium,characterized by bilateral renal tubular cyst formation
1995). The observation that patients with either PKD1and progressive enlargement (Gabow, 1993). ADPKD
or PKD2 share virtually identical clinical phenotypesresults in renal failure in z50% of affected individuals
by the age of 60. It affects between 1 in 600 and 1 in (Parfrey et al., 1990; Ravine et al., 1992) prompted spec-
1000 live births in all ethnic groups worldwide. Hepatic ulation that PKD1 and PKD2 are components of the
cysts arising from biliary epithelium are common and same signaling pathway. Recent studies have shown
increase with age, female sex, and number of pregnan- that PKD1 and PKD2 interact directly via their respective
cies (Everson, 1993). Additional extrarenal manifesta- cytoplasmic COOH-terminal domains (Qian et al., 1997;
tions include cysts in the pancreas and spleen, cardiac Tsiokas et al., 1997). Germline mutations in both genes
valvular abnormalities, and intracranial saccular aneu- appear to inactivate the mutant allele, and no clustering
rysms. of mutations has been observed in either gene (Peral et
PKD1, the gene mutated in 85% of ADPKD patients al., 1996; Roelfsema et al., 1997; Veldhuisen et al., 1997).
(Peters and Sandkuijl, 1992), is located in 16p13.3 and Recent studies of cyst-lining epithelial cells have dem-
encodes a 4303±amino acid integral membrane glyco- onstrated loss of heterozygosity (LOH) at the wild-type
protein, polycystin-1 (European Polycystic Kidney Dis- PKD1 allele (Qian et al., 1996; Brasier and Henske, 1997)
ease Consortium, 1994; American PKD1 Consortium, and have lead to the hypothesis that cyst formation in
PKD1 is the result of a clonal expansion of individual
cells acquiring second hits in the normal PKD1 allele6 To whom correspondence should be addressed.
7 These authors contributed equally to this work. (Qian and Germino, 1997).
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Figure 1. Targeting of the Pkd2 Locus by Homologous Recombination
(A) Schematic representation of the gene-targeting strategy. (i) Partial restriction map of the Pkd2 genomic locus. (ii) The Pkd2x1neo targeting
vector (2/4 PstI sites in PGK-NEO are shown). (iii) The expected mutant locus. Location of hybridization probes 1, 2, and 3 and of the 59 PCR
product are shown. (iv) Partial restriction map of the WS25 mutant locus showing insertion of the targeting vector into intron 1.
(B) ApaI-digested genomic DNA hybridized with probe 1 showing restriction patterns associated with WS25 genotypes (left panel). The same
pattern is obtained in the WS183 (null) mouse line. Hybridization with probe 3 (right panel) shows a doublet at 12±12.5 kb indicating two
copies of exon 1. This pattern is unique to the WS25 allele.
(C) Northern blot of total kidney RNA showing presence of the 5.2 kb Pkd2 mRNA in Pkd2WS25/WS25 mice. Human b-actin is used as loading
control.
(D) PstI (lanes 1, 3, and 5) and PstI/NotI digests (lanes 2, 4, and 6) showing continued presence of the wild-type PstI (4.0 kb) and PstI/NotI
(1.3 kb) fragments in Pkd2WS25/WS25 mice. Invariant 2.5 kb fragment is the aberrant exon 1* mutant allele. Note double intensity of the wild-type
fragments (4.0 and 1.3 kb) relative to the mutant (2.5 kb) allele in Pkd21/WS25 DNA.
No data are currently available on the mechanism of Results
cyst formation in PKD2. To investigate the role of PKD2
in the pathogenesis of ADPKD, we introduced targeted Generation of Pkd2 Mutant Mice
The mouse Pkd2 cDNA is predicted to encode an inte-mutations into the mouse homolog, Pkd2. The resulting
animal models faithfully recapitulate the human disease gral membrane protein with 91% sequence identity and
98% similarity to human polycystin-2 (Wu et al., 1997).and demonstrate that cyst formation occurs through a
cellular recessive mechanism. We isolated genomic clones containing the Pkd2 gene
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Northern blot analysis of total RNA from kidneys of
Pkd2WS25/WS25 mice revealed presence of wild-type Pkd2
mRNA at reduced levels (Figure 1C). No stable mRNA
species other than the wild-type 5.2 kb message were
identified. To determine if these mice produced stable
Pkd2 protein, we performed Western blot analysis with
polyclonal antisera, YCB9 and YCC2, directed against
cytoplasmic NH2- or COOH-terminal regions of polycys-
tin-2, respectively. Both antisera are made against epi-
topes downstream of the neor insertion, although the
immunogen for YCB9 included a portion of exon 1. Each
antiserum detected a single immunoreactive band mi-
grating at 110 kDa, identical to the wild-type protein
(Figure 2). Heterozygous and homozygous mutant mice
had reduced levels of Pkd2 protein, and the expres-
sion of Pkd2 varied widely among Pkd2WS25/WS25 miceFigure 2. Western Blot Detection of Polycystin-2 Protein
(Figure 2).
Pkd2 detected by COOH-terminal (top panel) and NH2-terminal (bot-
We produced a detailed restriction map of the WS25tom panel) anti-Pkd2 antisera. The two mice with the very low levels
Pkd2 locus in an effort to understand these findings.of protein (lanes 7 and 8) wereamong the four most severely affected
with kidney cysts. Mice in lanes 6 and 9 had mild cystic disease. Southern hybridization of ApaI-digested genomic DNA
The control for protein loadingutilized Coomassie brilliant blue stain- using probe 1 (Figure 1A) gave the expected pattern of
ing of the PVDF membrane after Western detection. A prominent 10 kb wild-type and 12 kb mutant alleles, verifying the
41 kDa band is shown to illustrate protein in each lane.
expected 39 integration event (Figure 1B). However, hy-
bridization of the same digest with the internal probe
3 revealed a doublet at 12 and z12.5 kb (Figure 1B),
and deduced the exon±intron organization of Pkd2 (Wu suggesting the existence of an additional copy of the
et al., unpublished data). Pkd2 has an equal number of probe 3 target sequence. The wild-type 4.0 kb PstI and
similarly sized exons as its human counterpart (Hayashi 1.3 kb PstI/NotI double-digest fragments were present
et al., 1997). A 7.5 kb EcoRI fragment containing the in DNA from Pkd2WS25/WS25 mice hybridized with probe 3
first coding exon of Pkd2 was subcloned into pUC19 (Figure 1D), indicating the continued presence of wild-
(Figure 1). Exon 1 was disrupted by introduction of a type exon 1. The PstI fragment representing the 59 up-
selectable neor cassette in the same transcriptional ori- stream portion of the disrupted exon 1* migrated at 2.5
entation as Pkd2 into the unique NotI site at codon 59 kb (Figure 1D) instead of the expected 1.8 kb (Figure 1A
(Figure 1A [ii]), introducing an in-frame stop codon nine [iii]). Pkd21/WS25 mice showed a greater relative intensity
codons downstream of the 59 cloning junction. The tar- of the 4.0 kb PstI fragment relative compared to the 2.5
geting vector Pkd2x1neo contained z7.5 kb of homolo- kb mutant allele, a finding consistent with increased
gous sequence extending 0.6 kb 59 and 6.9 kb 39 to the dosage of the wild-type exon 1 relative to the mutant
neor cassette. exon. Taken together, thesedata confirm theanomalous
Pkd2x1neo was introduced into WW6 ES cells (Ioffe nature of the 59 integration event and show that the
et al., 1995) by electroporation, and 196 colonies resis- targeting vector integrated into the first intron of Pkd2
tant to G418 were selected. Sequencing of PCR prod- without replacing the wild-type exon 1 (Figure 1A [iv])
ucts formed by primers outside the 59 end of Pkd2x1neo (Hasty et al., 1991).
and in the neor gene identified nine independent ES cell
clones with Pkd2 targeted by homologous recombina-
tion. ES cells from two subclones, WS25 and WS183, Kidney Cysts in WS25 Pkd2 Mutant Mice
were injected into C57Bl/6 blastocysts and implanted Both kidneys from 46 Pkd21/WS25 mice (age range 1±25
into pseudopregnant females. Chimeric male agouti off- weeks) and 17 Pkd2WS25/WS25 mice (age range 1±14 weeks)
spring were mated to C57Bl/6 females, and agouti F1 underwent histological examination. A cystic renal phe-
progeny were genotyped by Southern hybridization at notype was identified in three of the Pkd21/WS25 mice
3 weeks of age (Figure 1B). The WS25 mouse line was (aged 6, 8, and 14 weeks) and in nine of the Pkd2WS25/WS25
characterized first. mice (aged 4, 5, 8, 9, 10, 11, and 14 weeks) (Figure 3). In
Pkd21/WS25, renal cysts were unilateral and microscopic.
There were 2 to 5 discrete tubular cysts clustered in theAnalysis of the WS25 Pkd2 Mutant Allele
WS25 produced ten chimeric mice, of which five, exhib- cortex and/or outer medulla per kidney (Figures 3A and
3B). Early microcysts sometimes displayed mild epithe-iting 70%±90% chimerism, were mated. Of 149 agouti
F1 progeny, 69 (46%) were heterozygous for the WS25 lial hyperplasia (Figure 3C).
A more severe but considerably heterogenous renalmutation (Pkd21/WS25). Pkd21/WS25 mice derived from dif-
ferent chimeras were intercrossed and the F2 progeny phenotype was identified in Pkd2WS25/WS25 mice. Cysts
were bilateral in 8 of 9 mice, and affected kidneys werewere genotyped (Figure 1B): 23% were Pkd21/1, 57%
were Pkd21/WS25, and 20% were Pkd2WS25/WS25 (n 5 282), mildly enlarged with grossly identifiable translucent mac-
rocysts 0.5 to 4.0 mm in diameter. The bisected kidneysuggesting no deleterious effect of the Pkd2 targeting
event on early survival. surface area occupied by cysts ranged from 5% to 90%
Cell
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Figure 3. Kidney and Liver Cysts in the WS25 Pkd2 Mutant Mice
(A±C) kidneys of Pkd21/WS25; (D±J) kidneys of Pkd2WS25/WS25; (K±N) livers of Pkd2WS25/WS25.
(A) A bisected kidney shows sparse cysts clustered at the cortico-medullary junction (PAS, 32.5 [all magnifications given are for the original
figures]).
(B) Same kidney as in (A) illustrating the tendency of cysts to arise in the inner stripe of the outer medulla (PAS, 3120).
(C) An early kidney cyst displaying mild epithelial hyperplasia (H&E, 3250).
(D) Transillumination of the fresh, bisected kidney shows numerous cysts. Many of the cysts are clustered (32).
(E) Cross-section showing approximately 90% of the renal parenchyma occupied by large cysts, many with proteinaceous casts (H&E, 32.5).
(F) Relatively few medullary cysts in a kidney with 60% cortical involvement (PAS, 380).
(G) A glomerular cyst (H&E, 3250).
(H) A small cortical cyst lined by a thin monolayer of attenuated epithelium lacking brush border and filled with proteinaceous fluid (PAS,
3320).
(I) An incipient cyst arising as an outpouching from the wall of a tubule (PAS, 3320).
(J) Pericystic fibrosis and mild inflammation by mononuclear leukocytes (trichrome, 3250).
(K) Gross photograph of the cut surface of the liver shows a rounded cyst 4 mm in diameter (34).
(L) A hepatic cyst with a small septation surrounded by a thin rim of fibrous tissue (H&E, 3120).
(M) High power view of the cyst lining in (L) shows a single layer of slightly flattened, cuboidal biliary epithelium (H&E, 3250).
(N) The same liver as in (L) contains serpiginous intrahepatic clusters of small cysts lined by biliary epithelium and surrounded by inflamed
fibrous tissue (H&E, 3250).
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Figure 4. Cysts Arise from Distal Nephron
Segments
All sections are from Pkd2WS25/WS25 kidneys.
(A±C) Serial sections of five cysts: two stained
with antibody to Tamm-Horsfall protein (A),
two stained with lectin Dolichos biflorus (B),
and none stained with lectin Lotus tetragono-
lobus (C). The largest cyst fails to stain with
any marker. Noncystic tubules stained appro-
priately (DAB, hematoxylin, 380).
(D) Cyst stainedwith antibody to Tamm-Hors-
fall protein shows discontinuous staining of
the lining epithelium. Tamm-Horsfall protein
is also detected in the tubular lumen (DAB,
hematoyxylin, 3320).
(E) Two large cysts with circumferential in-
tense staining for lectin Dolichos biflorus
(DAB, hematoxylin, 3120).
(F) Staining for lectin Dolichos biflorus is inter-
rupted in this collecting tubular cyst. The
more flattened epithelial cells fail to markwith
the lectin (DAB, hematoxylin, 3320).
(G) Among the six cysts pictured, only one
stains with lectin Lotus tetragonolobus. Many
noncystic proximal tubules are marked in the
outlying cortex (DAB, hematoxylin, 3120).
(Figures 3D and 3E). Mice with the lowest expression of failure and in 75% of patients over the age of 60 (Ever-
son, 1993). Histological analysis on livers from 31Pkd2 (Figure 2, lanes 7 and 8) were the ones most se-
verely affected with renal cysts. In mice with milder phe- Pkd21/WS25 mice and 14 Pkd2WS25/WS25 mice identified he-
patic cysts in 3 Pkd2WS25/WS25 mice aged 4, 9, and 10notypic abnormalities, cysts occurred in the inner and
outer stripe of the outer medulla as well as the cortex weeks. Two of these mice were again the ones with the
lowest levels of Pkd2 (Figure 2, lanes 7 and 8). Oneand were often clustered (Figure 3B). In kidneys with
severe disease, cysts were also identified in the inner liver contained at least ten individual cysts ranging from
microcysts to 1 mm in size. Another contained a singlemedulla (Figure 3F). Glomerular cysts were rare (Figure
3G). Tubular cysts were lined by a monolayer of epithe- septated 4 mm macrocyst (Figure 3K). Cysts were lined
by a monolayer of cuboidal or flattened biliary epithe-lium ranging from cuboidal to hobnail or flattened. Most
cysts lacked a recognizable brush border, suggesting lium. Most cysts were rounded (Figures 3L and 3M),
whereas others displayed more convoluted, angulated,origin from the distal nephron (Figures 3H and 3I). Loose
proteinaceous casts were identified in cysts (Figures or branching contours (Figure 3N). Pkd2WS25/WS25 mice
exhibited a major extrarenal feature of ADPKD: liver3E, 3H, and 3J). Larger cysts were often septated (Figure
3G) and surrounded by atrophic renal parenchyma with cysts arising from bile duct epithelium.
interstitial fibrosis and mild inflammation (Figure 3J). The
noncystic renal parenchyma appeared normally de-
Segments of Origin of Renal Tubular Cystsveloped.
Using nephron segment±specific lectins Lotus tetra-
gonolobus (proximal tubule) and Dolichos biflorus (col-
lecting tubule) (Laitinen et al., 1987) and antibody toWS25 Pkd2 Mutant Mice Develop Liver Cysts
The most common extrarenal manifestation of ADPKD Tamm-Horsfall protein (distal tubule) (Hoyer and Seiler,
1979), the majority of renal cysts were found to involveis liver cysts, which occur in 50% of patients with renal
Cell
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Figure 5. Pkd2 Expression in Cysts
(A±D) Pkd21/1 kidneys; (E) Pkd21/WS25 kidney;
(F±H) Pkd2WS25/WS25 kidneys. YCC2 (COOH-ter-
minal) antiserum is used throughout.
(A) Intense Pkd2 reactivity is seen in the inner
stripe of outer medulla, corresponding to the
medullary thick ascending limbs. Individual
cortical tubules are also labeled and corre-
spond to cortical collecting tubules and distal
convoluted tubules (DAB, hematoxylin, 340).
(B) The inner medulla shows an abrupt transi-
tion between the positively stained thick as-
cending limbs in the inner stripe of outer me-
dulla and the negative thin limbs of Henle in
the inner medulla. Medullary collecting tu-
bules at the tip of the papilla are labeled (DAB,
hematoxylin, 340).
(C) Strong staining for Pkd2 is observed along
the basal aspect of the distal convoluted tu-
bules. A more narrow band of positive stain-
ing is seen along the base of a cortical collect-
ing tubule (DAB, hematoxylin, 3600).
(D) Proximal tubules display delicate verti-
cally oriented threads of positive staining
along the basal plasma membrane (DAB, he-
matoxylin, 3600).
(E) An early cyst from a Pkd21/WS25 kidney is
negative with immunostains for Pkd2. Multiple
positively stained distal tubules are seen in
the adjacent cortex (DAB, hematoxylin, 3250).
(F±H) Immunostains for Pkd2 protein are con-
sistently negative in cortical cysts, which
were identified as distal or collecting tubular
in origin in serial sections stained with seg-
ment-specific markers. Multiple positive non-
cystic tubules are seen (DAB, hematoxylin,
[F] 380, [G] 3120, [H] 3250).
the more distal portions of the nephron (Figure 4). A from the basal membrane into the basal cytoplasm (Fig-
ure 5C). A more narrow and slightly less intense bandmean 40%of cysts wereof collectingtubular origin, 42%
distal tubular origin, and 5% proximal tubular origin. of basal cytoplasmic and membrane staining was identi-
fied in the cortical and medullary collecting tubules.Thirteen percent of cysts failed to stain with any marker.
The latter included glomerular cysts and some extremely Much weaker and more delicate staining outlined the
basal cell membrane of the proximal tubules (Figure 5D).large macrocysts. Some of the larger cysts displayed
skip areas with discontinuous lectin staining over short No staining was observed in the glomerular tuft, visceral
or parietal epithelium, thin limbs of Henle, interstitium,segments of the cyst wall (Figures 4D and 4F). These
findings are consistent with previously reported data or blood vessels. This pattern of expression is similar
to that observed in human kidneys (Y. Cai et al., unpub-for human ADPKD indicating that cysts may affect all
segments of the neprhon. However, in these mice there lished data).
Kidneys of Pkd21/WS25 mice with normal renal pheno-is a clear predilection for cysts to arise from the more
distal nephron segments, a finding that has not been type displayed an intensity and distribution of Pkd2 im-
munostaining indistinguishable from wild-type kidneys.conclusively investigated in human ADPKD.
Heterozygote kidneys with a cystic phenotype displayed
complete absence of immunoreactivity for polycystin-2Loss of Polycystin-2 Expression Leads
to Cyst Formation in renal cysts, with retention of normal staining in adja-
cent noncystic tubules (Figure 5E).Immunostains for Pkd2 in wild-type mouse kidney using
the YCC2 antiserum revealed a highly segment-specific Cysts in Pkd2WS25/WS25 kidneys showed localized com-
plete absence of Pkd2 immunostaining throughout theepithelial staining pattern (Figures 5Aand 5B). Strongest
reactivity for Pkd2 was observed in thedistal convoluted epithelium of every renal cyst, irrespective of cyst size
or nephron segment of origin (Figures 5F±5H). The seg-tubules and medullary thick ascending limbs of Henle.
In both segments, staining was basolateral, extending ment-specific staining studies demonstrate that cysts
Somatic Mutation in Polycystic Kidney Disease
183
in Pkd2 mutant mice preferentially arise from the regions
of the nephron that express Pkd2 most highly. Yet, the
cells lining these cysts uniformly do not express Pkd2,
while it is expressed in the surrounding noncystic re-
gions. This lack of polycystin-2 expression is not a result
of profound de-differentiation, since staining of serial
sections shows that cystic epithelia still express seg-
ment-specific markers. We conclude that a subset of
tubular epithelial cells lose the capacity to express poly-
cystin-2, and these cells give rise to cysts in the WS25
mutant mouse line.
Intragenic Recombination Inactivating Both Pkd2
Alleles Results in Cyst Formation
The complete loss of Pkd2 expression in cyst-liningcells
suggests that a cellular recessive mechanism is respon-
sible for cyst formation in the WS25 mutant line. It is
necessary to reconcile the nature of the WS25 mutation,
which allows continued expression of Pkd2, with the
observed loss of Pkd2 expression in cyst-lining cells.
Several lines of experimental evidence suggest a likely
explanation. Two Pkd2WS25/WS25 mice with pathologically
very severe cystic disease and extremely low levels of
Pkd2 (Figure 2, lanes 7 and 8) have a novel 1.8 kb PstI
restriction fragment when probed with the exon 1±spe-
cific probe 3 (Figure 6A). This 1.8 kb PstI fragment was
not present in the genomic DNA of the parents of either
mouse nor did any of their littermates share this allele.
The occurrence of a novel 5.0 kb HindIII allele, detected
by the same probe (data not shown), in mice with the 1.8
kb PstI fragment suggests that these novel restriction
fragments are the result of a genomic rearrangement.
To test the hypothesis that genomic rearrangement
results in loss of Pkd2 expression and gives rise to cyst
formation, we prospectively screened 61 Pkd2WS25/WS25
and 102 Pkd21/WS25 mice for presence of the 1.8 kb PstI
fragment. Two additional Pkd2WS25/WS25 mice had this al-
lele and were affected with grossly visible cysts (Figure
6B). None inherited this allele from their parents. The
1.8 kb PstI allele was not observed in the five other
homozygous mice with cysts. No Pkd21/WS25 mice had
this restriction fragment.
Based onthe thegenomic structure of theWS25 allele,
we suggest that genomic rearrangement is mediated
by intragenic homologous recombination between tan-
demly repeated portions of the wild-type and mutantFigure 6. Genomic Rearrangement in the WS25 Allele
exon 1 (Figure 6C). Such an event involving portions of(A) PstI digest of tail biopsy genomic DNA probed sequentially with
the wild-type and mutant exon 1 upstream of the NotIprobe 2 followed by probe 3. Probe 2 detects the wild-type 4.0 kb
allele and a 3.4 kb mutant allele. Probe 3 detects the wild-type 4.0 site and neor cassette, respectively, would bring the PstI
kb and the mutant 2.5 kb allele (Figure 1D). In lanes 2 and 6, DNA and HindIII sites upstream of the wild-type exon 1 into
from the mice with very low protein levels and the severe cystic the proximity of the neor cassette (Figure 6C). The 1.8
phenotype (Figure 2, lanes 7 and 8) reveal a novel 1.8 kb PstI frag-
kb PstI and the 5.0 kb HindIII fragments are producedment detected by probe 3. Strong signal at 4.0 kb and 1.0 kb in
by the respective upstream sites and sites in neor. Thislanes 6 and 7 is due to cross-hybridization with a high copy number
(z1000) b-globin transgene present in the WW6 ES cell line (Ioffe
et al., 1995).
(B) Prospective screening of 61 Pkd2WS25/WS25 and 102Pkd21/WS25 mice
for presence of the 1.8 kb PstI fragment. Shown is a panel of 11 by unequal sister chromatid exchange. Arrows represent location
digests from Pkd2WS25/WS25 mice, with lane 1 having the additional of PCR primers producing the 832 bp product (PCR) in the null
1.8 kb allele. This mouse had very severe, grossly visible cystic allele after recombination. The asterisks mark enzyme sites that are
involvement of both kidneys. brought together by recombination to form the novel 1.8 kb PstI
(C) Schematic representation of intragenic homologous recombina- and 5.0 kb HindIII fragments.
tion in the WS25 allele. Recombination r1 produces a null allele (D) Southern hybridization of PCR products using an internal probe.
(shown), while the recombination r2 produces a wild-type allele. The signal corresponds to the 832 bp product formed by intragenic
Shown on a single strand for illustration, this process could occur recombination on the WS25 allele.
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PstI and HindIII restriction pattern was the one expected Pkd2WS25/WS25 mice. The requirement for a naturally oc-
curring somatic mutation in the normal allele would ex-if the initial gene targeting event had resulted in replace-
plain the very low rate of cyst formation observed in thement of wild-type exon 1 (Figure 1A [iii]). Thus, the allele
heterozygous WS25 mice.resulting from intragenic recombination 59 to the neor
These findings would suggest that mice heterozygouscassette is predicted to produce a true null allele defi-
for a true null allele would develop cystic kidneys at acient in active and immunoreactive polycystin-2.
higher rate than WS25 heterozygotes. Compound cis-If the intragenic recombination event occurs 39 to the
heterozygote mice with one true null allele for Pkd2 andneor cassette, itwould be predicted to form the wild-type
one WS25 allele would reliably and reproducibly developallele (Figure 6C). The latter event would be predicted to
ADPKD and could serve as a practical model of thebe more frequent than the 59 recombination since the
human disease.region of homology 39of theneor cassette ismuch larger.
To test for reversion to the wild-type allele, we geno-
typed 30 progeny from a [Pkd2WS25/WS25] 3 [Pkd2WS25/WS25] ADPKD in Mice with a True Null Allele
intercross by hybridization of probe 1 to ApaI digests. We next analyzed the mouse line derived from the
Twenty-five mice were Pkd2WS25/WS25 and five mice were WS183 ES cell clone to determine if this line had under-
Pkd21/WS25, demonstrating the occurrence of the pre- gone the expected exon 1 replacement and given rise
dicted genomic rearrangement reverting to the wild- to a true null allele (Figure 1A [iii]). WS183 produced six
type allele. chimeric mice, of which three were mated. Of the 36
Southern blot evidence of genomic rearrangement re- agouti F1 progeny, 14 (38%) were found to be heterozy-
quires substantial dosage of the recombined allele in gous for the WS183 mutation (Pkd21/2) upon genotyping
the tissue being tested. Such a dosage can be achieved of ApaI-digested DNA with probe 1. Adult F2 progeny
if the intragenic recombination occurs in the parental of the Pkd21/2 intercross (n 5 73) showed 32% Pkd21/1
germline or as a somatic event early in embryogenesis. and 68% Pkd21/2, suggesting that Pkd22/2 mice were
To demonstrate that rearrangement forming the null al- not viable. Forty-four embryos (E13±15) from the same
lele was occurring in the tissues of mice without any intercross showed Mendelian ratios: 25% Pkd21/1, 47%
novel restriction fragments, we analyzed mouse tail Pkd21/2, and 28% Pkd22/2. No ApaI 12 kb doublet was
biopsy and tissue-specific genomic DNA by PCR with detected with probe 3 in WS183 mice. Probe 3 hybrid-
the primer pairs used in the original ES cell screening ized to the wild-type 4.0 kb band and the expected 1.8
(Figure 6C). We formally excluded the existence of a kb band on PstI-digested genomic DNA without evi-
duplication of the region upstream of exon 1 at the 59 dence of the aberrant 2.5 kb fragment seen in WS25
end of the targeting vector integration site by hybridizing (Figure 7A). Western blots of total protein extracted from
a 195 bp genomic PCR product to PstI-digested geno- embryos showed reduced levels of protein in Pkd21/2
mic DNA from mutant animals. This 195 bp probe con- and complete absence of Pkd2 protein in Pkd22/2 mice
tained both forward PCR primers used in the nested (Figure 7B).
PCR screen and hybridized only to the wild-type 4.0 kb Detailed histological examination of both kidneys
PstI fragment, confirming that the forward primers were from 29 Pkd21/2 mice (age range 9±17 weeks) showed
single copy and located upstream of the wild-type exon the presence of 1 to 5 unilateral renal cysts in six mice
1 (Figure 6C). The expected 832 bp nested PCR product (21%) (Figure 7C). In addition, two Pkd21/2 mice had 1 to
can only be amplified from WS25 genomic DNA if intra- 2 liver cysts and a third animal had bile duct proliferation
similar to that seen in ADPKD (not shown). Immunostain-genic homologous recombination has occurred in at
ing of the cysts in five kidneys showed absence of Pkd2least a subset of cells. Amplification of genomic DNA
expression in the cyst-lining cells (Figure 7D); the sixthfrom Pkd2WS25/WS25 and Pkd21/WS25 mice produced an 832
kidney was not available for staining. Pkd21/2 mice hadbp PCR product detectable by hybridization with an
a phenotype intermediate in severity as judged by fre-internal hybridization probe (Figure 6D). The identity of
quency of occurrence and spectrum of organ systemthis product with the expected product was confirmed
involvement between Pkd21/WS25 and Pkd2WS25/WS25 ani-by direct sequencing. In retrospect, our original PCR
mals. These mice likely represent a true model of humanscreen of the WS25 ES cell line was positive because a
ADPKD.subset of the ES cells had undergone this recombination
during expansion of the clones. However, the cells that
transmitted through thegermline from our chimericmice Severe ADPKD in Pkd2WS25/2 Mice
had a WS25 allele that had not undergone this re- We intercrossed Pkd21/2 mice with either Pkd21/WS25
arrangement. or Pkd2WS25/WS25 animals to obtain compound cis-hetero-
The occurrence of genomic rearrangement affecting zygous Pkd2WS25/2 mice.Pkd2WS25/2 animalsescape the em-
both Pkd2 alleles in a single cell is the mechanism by bryonic lethality of the Pkd22/2 genotype. The [Pkd21/2] 3
which individual cells lose the ability to express Pkd2 [Pkd21/WS25] intercross (n 5 52) yielded 33% Pkd21/1,
and become cyst-forming cells in Pkd2WS25/WS25 mice. 46% heterozygous (Pkd21/2 or Pkd21/WS25), and 21%
Similarly, in Pkd21/WS25 mice the WS25 allele undergoes Pkd2WS25/2. The [Pkd21/2] 3 [Pkd2WS25/WS25] intercross
rearangement and, in addition, the normal allele must (n 5 70) yielded 4% (n 5 3) Pkd21/1, 47% Pkd21/2 or
sustain a naturally occurring somatic mutation or gene Pkd21/WS25, and 49% Pkd2WS25/2. The occurrence of
conversion. The requirement for doubly affected cells Pkd21/1 in the latter cross and the suggestion of a skew
to initiate cyst formation would explain the variability in in the former is the result of rearrangement in WS25 to
form the wild-type allele.the occurrence and severity of cysts noted in these
Somatic Mutation in Polycystic Kidney Disease
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Figure 7. The Pkd2 Null Mutation
(A) PstI digest of genomic DNA probed with probe 3 detects the wild-type 4.0 kb allele and the mutant 1.8 kb allele.
(B) Pkd2 detected by COOH-terminal antisera in total protein (15 mg) from embryo homogenates. Pkd21/2 mice have reduced expression and
Pkd22/2 mice have absent expression.
(C) Pkd21/2 kidney with two large cortical cysts (H&E, 320).
(D) The same kidney as in (C) showing absence of immunostaining for Pkd2 in cystic epithelium (DAB, hematoxylin, 380).
(E) Whole mount of Pkd2WS25/2 kidney with approximately 60% of the parenchyma occupied by cysts, many with proteinaceous casts
(H&E, 32.5).
(F) All cortical and outer medullary cysts stain negative for Pkd2 with YCC2 antiserum. The wild-type pattern of staining is seen in the noncystic
parenchyma (DAB, hematoxylin, 340).
(G) ADPKD phenotypes associated with Pkd2 mutant genotypes.
Six Pkd2WS25/2 mice sacrificed at 10±11 weeks all had phenotype as predicted by our model. With one null
allele, any tubular cell undergoing the 59 rearrangementbilateral renal cysts involving 20%±75% (mean, 45%) of
the cut surface area of each kidney (Figure 7E). All six on the WS25 allele becomes deficient in Pkd2 and goes
on to form cysts.mice had 1 to 10 liver cysts and 3 of 6 also had bile
duct proliferation. Cyst-lining cells in all 12 kidneys were
uniformly negative for immunostaining with the YCC2 Discussion
antiserum (Figure 7F). Figure 7G summarizes the sever-
ity in the ADPKD phenotype associated with the various We have produced four animal models of PKD2 that
recapitulate the human ADPKD phenotype. All of thesemutantgenotypes. Pkd2WS25/2 mice have the most severe
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models show continued production of Pkd2 and are has to occur on the normal Pkd2 allele. Cyst formation
is more common in Pkd21/2 than Pkd21/WS25 mice sincetherefore functionally analogous to the heterozygous
human disease state. Kidneys form normally in the mu- the latter must undergo rearrangement of the WS25
allele as well. Since mutations of the normal allele maytant mice, and cysts arise as focal outpouchings from
the walls of normal, mature tubules. The cysts are lined involve missense changes, the absence of Pkd2 im-
munostaining in cyst walls of heterozygous mice mayby an attenuated, flattened epithelium, some with hy-
perplastic features. Initially, cyst lining cells retain a dif- be a consequence of the relatively small total num-
ber of cysts examined, the use of a COOH-terminal anti-ferentiated cell type but subsequently show loss of
nephron segment±specific surface markers. In the liver, body, or instability of the mutant mRNA or translation
products.biliary epithelia give rise to cysts. Fibrosis with mild
inflammation is seen surrounding renal and hepatic LOH for PKD1 has been observed in cyst-lining cells
in human ADPKD (Qian et al., 1996; Brasier and Henske,cysts. The histologic features of the renal cystic disease
in mutant mice are virtually identical to those described 1997; Qian and Germino, 1997). The causal nature of
this finding has been challenged (Harris and Watson,for human ADPKD (Evan and McAteer, 1992; Gabow
and Grantham, 1997). These results show that mutation 1997; Ong and Harris, 1997). It has been proposed that
PKD2 results from clonal expansion of compound trans-in the mouse homolog of PKD2 can cause renal cystic
disease and provide functional proof that PKD2 muta- heterozygote cells with a germline inactivating mutation
in PKD2 and a somatic mutation in PKD1 (Qian et al.,tions are pathogenic in ADPKD.
1996; Qian and Germino, 1997). Our current data provide
evidence for an alternative hypothesis. Cyst formation
A Cellular Recessive Mechanism in PKD2 requires inactivation of both Pkd2 alleles. We
for Cyst Formation have not observed any cysts in our models that express
Cysts arise from cells that lose the ability to express Pkd2 protein as would be expected in a cyst arising by
functional Pkd2. There is loss of polycystin-2 expression a compound trans-heterozygote mechanism. In hetero-
in all renal cyst lining cells. The majority of these cells zygous mice, absence of Pkd2 immunostaining in cysts
are derived from nephron segments that express Pkd2 indicates that somatic mutations have affected the nor-
highly, so this finding is not the result of limiting detec- mal Pkd2 allele. We suggest that cysts in human PKD2
tion of immunoreactivity. The severity of cyst formation also arise as a consequence of two hits at the PKD2
is enhanced by the presence of the WS25 mutation. This locus. With evidence for homozygous LOH at Pkd2 in
allele is unstable and undergoes somatic conversion to our mice and without direct evidence for a compound
a null (or wild-type) allele in vivo. The propensity for this trans-heterozgote mechanism, it is possible that the so-
rearrangement is a direct result of the structure of the matic mutation rates for the respective regions of the
WS25 Pkd2 mutation. WS25 contains wild-type and mu- human genome are sufficient to account for the ob-
tant exon 1 and flanking intronic sequences in tandem, served rates of cyst formation in PKD1 and PKD2 (Qian
allowing for intragenic homologous recombination by and Germino, 1997). PKD2 families are less common
either unequal sister chromatid exchange or intrastrand than PKD1 because mutations at PKD2 occur less fre-
recombination (Lifton et al., 1992; Ellis and German, quently in the population. The rate of cyst formation in
1996; Chen et al., 1997). When both alleles in a tubular PKD2 is slower because the rate of somatic mutation
epithelial cell become null for Pkd2, that cell expands at this locus is less than at PKD1. An assessment of the
clonally and a cyst ensues (Qian et al., 1996). contribution to cyst formation of LOH at PKD2 relative to
Variable expression of Pkd2 from the WS25 allele may the compound trans-heterozygote mechanism inhuman
result from position effects of the intron 1 insertion and disease remains to be investigated. Studies on human
variability in the proportion of null alleles generated by PKD2 cyst tissues and mating of Pkd11/2 with Pkd21/2
genomic rearrangement as well as possible genetic mice should yield additional insights into these issues.
background effects. In Pkd2WS25/WS25 mice, the likelihood
of two intragenic recombination events occurring inde- Pkd2 and the Kidney
pendently in one cell is low. Mice that are most likely Cyst-lining cells are thought to be locked into an inter-
to have a large number of cysts are those in which the mediate state of differentiation as a consequence of a
initial recombination occurs in the parental germline or cystogenic event (Calvet, 1993). Perhaps the de-differ-
early in embryonic development. In either event, a sub- entiation hypothesis can now be refined to state that,
stantial proportion of cells in the organism will have one as a consequence of a molecular lesion in the PKD2
null allele. The dosage of the recombined allele in such pathway, individual tubular epithelial cells lose theability
mice may be sufficient to allow Southern blot detection to receive specific information regarding tissue organi-
of novel restriction fragments, accounting for our obser- zation. In the absence of this contextual information,
vation of these fragments in some severely affected they proliferate abnormally, change their specialized
mice. The greater the proportion of cells affected by phenotypes, and expand into cystic structures. Our
one null allele, the closer the rate of cyst formation ap- Pkd2 mutant mice have shown that Pkd2 is essential
proximates the rate of null allele formation by the WS25 for the maintenance of the mature differentiated neph-
allele. This prediction is borne out by the observation ron and biliary architecture. A tight functional connec-
that Pkd2WS25/2 mice get a severe and reproducible form tion between PKD1 and PKD2 is suggested by the virtual
of ADPKD. identity of the respective disease phenotypes and by
In heterozygous Pkd21/WS25 and Pkd21/2 mice, inacti- demonstration of direct interaction between the respec-
tive protein products. Pkd1 mutant mice fail to establishvating mutation or gene conversion in cyst-forming cells
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0.8 kb mouse cDNA clone just downstream of the NotI site wasnormal renal tubule and pancreatic ductal architecture
used as the hybridization probe.(Lu et al.,1997). Pkd22/2 mice exhibit a similar embryonic
lethal phenotype (Wu et al., unpublished data). This sug-
Antibodies and Western Blot Analysisgests that Pkd2 is also essential to the establishment of
Rabbit polyclonal antisera to GST fusion proteins containing amino
normal renal tubular and pancreatic ductal architecture. acids 687±962 (YCC2) and 103±203 (YCB9) of polycystin-2 were
Finally, the WS25 mouse line represents an alternative produced and characterized in detail (Y. Cai, unpublished data). For
Western blot analysis, 15 mg of total protein from lung or wholemeans of producing mouse models with somatic inacti-
fetus homogenate was separated on 8% SDS-polyacrylamide gelsvation of an allele that may prove useful in studying the
and transferred onto PolyScreen PVDF membranes (DuPont/NEN).ever-increasing list of human diseases resulting from
The membranes were blocked by 5% nonfat dry milk/PBS and incu-somatic second hits (Qian and Germino, 1997), particu-
bated with anti-polycystin-2 polyclonal antisera (YCC2 [1:5000] or
larly those that are lethal during embryogenesis in the YCB9 [1:4000]) in the blocking buffer. Bound protein was detected
null state. This paradigm could be applied to other ªsec- by ECL-enhanced chemiluminescence (DuPont/NEN). Total protein
transferred to the membranes was demonstrated by staining withond hitº kidney-related phenotypes such as PKD1, von
Coomassie brilliant blue (Figure 2, control).Hippel Lindau, and tuberous sclerosis complex 2 or even
to the broader class of tumor suppressor gene models
Histology and Immunohistochemistry Studiesof human disease.
Tissues were fixed in 10% phosphate-buffered formalin and embed-
ded in paraffin. Twenty-step sections of kidney and five-step sec-
Experimental Procedures tions of liver were stained with hematoxylin-eosin, periodic acid,
and Schiff and Masson's trichrome stains. A complete histologic
Pkd2 Gene Targeting and ES Cell Screening survey was performed on three Pkd21/WS25 and three Pkd2WS25/WS25
Mouse cDNA clone inserts (Wu et al., 1997) were used to screen mice with renal cysts.
1.2 3 106 plaques of a mouse 129/Ola genomic library constructed Lectin studies were performed on 3 mm sections of kidney tissue
in Charron 35. Fourteen positively hybridizing l clones were ob- as previously described (D'Agati and Trudel, 1992). Kidney tissue
tained, and a clone containing the 59 end of the gene was identified was stained with YCC2 antibody as described previously (D'Agati
by Southern hybridization and restriction mapping. The Pkd2x1neo and Trudel, 1992). YCC2 antibody (1:5000) was applied overnight
targeting vector was constructed (Figure 1A [ii]) and 30 mg of vector at 48C. Rabbit anti-mouse Tamm-Horsfall antibody (1:1000) (gift of
DNA was linearized at the unique vector SalI site and electroporated Dr. John Hoyer) was used for detection of distal tubules.
into 2.5 3 107 clone WW6 ES cells (Ioffe et al., 1995). ES cell culture,
electroporation, and selection with G418 were performed as de- Acknowledgments
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